Yoshiro Tsukiyama Selected Research

Stents

1/2023	Stentless percutaneous coronary intervention with directional coronary atherectomy and drug-coated balloon angioplasty in worsening angina patients with metal allergies.
4/2022	A serial optical frequency-domain imaging study of early and late vascular responses to bioresorbable-polymer sirolimus-eluting stents for the treatment of acute myocardial infarction and stable coronary artery disease patients: results of the MECHANISM-ULTIMASTER study.
12/2020	Comparison of the 9-Month Intrastent Condition and 30-Month Clinical Outcomes After Resolute Zotarolimus-Eluting Stent Implantation Between Standard-Duration and 1-Month Dual Antiplatelet Therapy Followed by Prasugrel Monotherapy.
10/2020	Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease.
10/2019	Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).
1/2019	Impaired Cholesterol-Uptake Capacity of HDL Might Promote Target-Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation.
11/2018	Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.
5/2016	Optical coherence tomography study of chronic-phase vessel healing after implantation of bare metal and paclitaxel-eluting self-expanding nitinol stents in the superficial femoral artery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiro Tsukiyama Research Topics

Disease

5	Thrombosis (Thrombus) 01/2023 - 11/2018
5	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 10/2017
4	Atherosclerotic Plaque (Atheroma) 01/2020 - 10/2017
3	Myocardial Infarction 04/2022 - 10/2020
3	Neointima 10/2019 - 05/2016
2	ST Elevation Myocardial Infarction 04/2022 - 10/2020
1	Pathologic Constriction (Stenosis) 01/2023
1	Angina Pectoris 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Decompression Sickness (Bends) 12/2022
1	Hemorrhage 12/2020
1	Acute Coronary Syndrome 11/2018
1	AIDS-Related Complex (ARC) 10/2017

Drug/Important Bio-Agent (IBA)

2	Prasugrel Hydrochloride FDA Link 12/2020 - 11/2018
2	alirocumabIBA 01/2020 - 01/2019
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2020 - 01/2019
1	MetalsIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	PolymersIBA 04/2022
1	Sirolimus (Rapamycin)FDA Link 04/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020
1	CobaltIBA 10/2020
1	Everolimus FDA Link 10/2020
1	ChromiumIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Trans Fatty AcidsIBA 10/2017
1	LipidsIBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017

Therapy/Procedure

8	Stents 01/2023 - 05/2016
2	Percutaneous Coronary Intervention 01/2023 - 01/2019
2	Drug-Eluting Stents 12/2020 - 10/2020
1	Catheters 12/2022
1	Therapeutics 11/2018